Cargando…

Measles and rubella seroprevalence among adults in Georgia in 2015: helping guide the elimination efforts

A large-scale measles outbreak (11 495 reported cases, 60% aged ≥15 years) occurred in Georgia during 2013–2015. A nationwide, multistage, stratified cluster serosurvey for hepatitis B and C among persons aged ≥18 years conducted in Georgia in late 2015 provided an opportunity to assess measles and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khetsuriani, N., Chitadze, N., Russell, S., Ben Mamou, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003625/ https://www.ncbi.nlm.nih.gov/pubmed/31822310 http://dx.doi.org/10.1017/S0950268819002048

Ejemplares similares

Challenges to Achieving Measles Elimination, Georgia, 2013–2018
por: Khetsuriani, Nino, et al.
Publicado: (2020)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023)

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination
por: Winter, Amy K, et al.
Publicado: (2018)

Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2022)

Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018
por: Brown, Kevin E., et al.
Publicado: (2019)

Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa
por: Richardson, Lauren Christine, et al.
Publicado: (2020)

Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran
por: Saffar, Hana, et al.
Publicado: (2021)

Strengthening routine immunization through measles-rubella elimination
por: Biellik, Robin J., et al.
Publicado: (2018)

Towards elimination of measles and rubella in Italy: Progress and challenges
por: Adamo, Giovanna, et al.
Publicado: (2019)

Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
por: Wang, Zhifang, et al.
Publicado: (2014)

Measles and Rubella Seroprevalence in Mother–Infant Pairs in Rural Nepal and the United States: Pre- and Post-Elimination Populations
por: Murray, Alastair F., et al.
Publicado: (2018)

How Australia’s measles control activities have catalyzed rubella elimination
por: Glynn-Robinson, Anna, et al.
Publicado: (2022)

Progress Toward Measles and Rubella Elimination — India, 2005–2021
por: Murugan, Ratnesh, et al.
Publicado: (2022)

Progress Toward Measles and Rubella Elimination — Indonesia, 2013–2022
por: Chacko, Stephen, et al.
Publicado: (2023)

Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study
por: Jablonka, Alexandra, et al.
Publicado: (2017)

Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination
por: Hagan, Liesl M., et al.
Publicado: (2019)

Measles and rubella seroprevalence in a population of young adult blood donors, France 2013
por: Antona, D., et al.
Publicado: (2019)

1171. Measles and Rubella Seroprevalence among HIV-infected and uninfected Children and Adults in Zambia
por: Yang, Yangyupei, et al.
Publicado: (2021)

Seroprevalence of Antibodies to Measles, Mumps, and Rubella among Thai Population: Evaluation of Measles/MMR Immunization Programme
por: Tharmaphornpilas, Piyanit, et al.
Publicado: (2009)

Progress Toward Rubella Elimination — World Health Organization European Region, 2005–2019
por: O’Connor, Patrick, et al.
Publicado: (2021)

Assessment of Economic Burden of Concurrent Measles and Rubella Outbreaks, Romania, 2011–2012
por: Njau, Joseph, et al.
Publicado: (2019)

Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants
por: Cho, Hye-Kyung, et al.
Publicado: (2016)

1209. Seroprevalence of Measles, Mumps, and Rubella in Korean Healthcare Workers and Strategy for Vaccination
por: Ju Choo, Eun, et al.
Publicado: (2019)

Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia
por: Carcelen, Andrea C., et al.
Publicado: (2021)

A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents
por: Nokhodian, Zary, et al.
Publicado: (2022)

Singapore’s efforts to achieve measles elimination in 2018
por: See, Wanhan, et al.
Publicado: (2021)

Immunogenicity of measles-rubella vaccine administered under India’s Universal Immunization Programme in the context of measles–rubella elimination goal: A longitudinal study
por: Verma, Santosh Kumar, et al.
Publicado: (2023)

P280: Seroprevalence of measles, rubella, mumps, and varicella among health care workers in Japan
por: Watanabe, T, et al.
Publicado: (2013)

Case Based Measles Surveillance in Pune: Evidence to Guide Current and Future Measles Control and Elimination Efforts in India
por: Bose, Anindya Sekhar, et al.
Publicado: (2014)

Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study
por: Winter, Amy K, et al.
Publicado: (2022)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic
por: Manirakiza, Alexandre, et al.
Publicado: (2011)

Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
por: Lebo, Emmaculate J., et al.
Publicado: (2015)

Seroprevalence of Anti-Rubella and Anti-Measles IgG Antibodies in Pregnant Women in Shiraz, Southern Iran: Outcomes of a Nationwide Measles-Rubella Mass Vaccination Campaign
por: Honarvar, Behnam, et al.
Publicado: (2013)

Seroprevalence of Antibodies against Measles, Rubella and Varicella among Asylum Seekers Arriving in Lower Saxony, Germany, November 2014–October 2015
por: Toikkanen, Salla E., et al.
Publicado: (2016)

Measles Elimination Efforts and 2008–2011 Outbreak, France
por: Antona, Denise, et al.
Publicado: (2013)

A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination
por: Prausnitz, Mark R, et al.
Publicado: (2020)

Investing in global measles and rubella elimination is needed to avert deaths and advance health equity
por: Raghunathan, Pratima L, et al.
Publicado: (2022)

Seroprevalence of measles, mumps, rubella, varicella–zoster and hepatitis A–C in Emirati medical students
por: Sheek-Hussein, Mohamud, et al.
Publicado: (2012)

Seroprevalence of measles, mumps, rubella, and varicella-zoster antibodies in new female nurses in the Republic of Korea
por: Yoo, Yeongjae, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_db6ls9qep2t2aplcass4p0r0j3